All Stories

  1. Qualitative factors shaping MS patients’ experiences of infusible disease-modifying drugs: a critical incident technique analysis

    Article • BMJ Open, August 2020, BMJ

    Ms Janni Lisander Larsen

  2. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Article • Annals of the Rheumatic Diseases, March 2019, BMJ

    Ms Janni Lisander Larsen, myrto kostopoulou

  3. Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status

    Article • PLOS One, March 2018, PLOS

    Ms Janni Lisander Larsen

  4. The existential experience of everyday life with systemic lupus erythematosus

    Article • Journal of Advanced Nursing, February 2018, Wiley

    Ms Janni Lisander Larsen

  5. Being in a standstill-of-life

    Article • Scandinavian Journal of Caring Sciences, July 2017, Wiley

    Ms Janni Lisander Larsen

  6. Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients

    Article • Journal of Immunology Research, January 2016, Hindawi Publishing Corporation

    Ms Janni Lisander Larsen

  7. Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patients

    Article • Lupus Science & Medicine, April 2014, BMJ

    Ms Janni Lisander Larsen

  8. Rapid infusion with rituximab: short term safety in systemic autoimmune diseases

    Article • Rheumatology International, November 2011, Springer Science + Business Media

    Ms Janni Lisander Larsen